CIK 0000313143 · Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- operating
- EIN
- 042882273
- Phone
- 7818487100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-16 | Basil Michelle L EVP and General Counsel | Grant or award · Non-qualified Stock Option (Right to Buy) | +14,208 | 14,208 | ||
| 2022-05-16 | DArecca James EVP, Chief Financial Officer | Grant or award | +4,774 | 10,676 | ||
| 2022-05-16 | DArecca James EVP, Chief Financial Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +11,163 | 11,163 | ||
| 2022-05-16 | Simon, Christopher President & CEO | Sale | −832 | $56.10 | $47K | 191,327 |
| 2022-05-16 | Simon, Christopher President & CEO | Grant or award | +26,041 | 217,368 | ||
| 2022-05-16 | Simon, Christopher President & CEO | Grant or award · Non-qualified Stock Option (Right to Buy) | +60,891 | 60,891 | ||
| 2022-05-02 | DArecca James EVP, Chief Financial Officer | Grant or award | +5,902 | 5,902 | ||
| 2022-05-02 | DArecca James EVP, Chief Financial Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +13,828 | 13,828 | ||
| 2022-04-18 | Lingamneni Anila EVP, Chief Technology Officer | Sale | −189 | $56.55 | $11K | 14,013 |
| 2021-10-25 | Strong Stewart W President, Global Hospital | Sale | −75 | $71.93 | $5K | 12,717 |
| 2021-10-25 | Basil Michelle L EVP and General Counsel | Sale | −120 | $71.93 | $9K | 38,290 |
| 2021-09-17 | Miller Laurie A. SVP, Human Resources | Grant or award | +2,848 | 10,081 | ||
| 2021-09-07 | Llorens Josep EVP, Global Manufacturing | Sale | −100 | $64.61 | $6K | 14,520 |
| 2021-08-23 | Burke William P. Mr. EVP, Chief Financial Officer | Option exercise | +11,232 | $34.21 | $384K | 41,523 |
| 2021-08-23 | Burke William P. Mr. EVP, Chief Financial Officer | Option exercise | +11,435 | $41.64 | $476K | 52,958 |
| 2021-08-23 | Burke William P. Mr. EVP, Chief Financial Officer | Sale | −22,667 | $60.51 | $1.4M | 30,291 |
| 2021-08-23 | Burke William P. Mr. EVP, Chief Financial Officer | Option exercise · Non-qualified Stock Option (Right to Buy) | −11,232 | 0 | ||
| 2021-08-23 | Burke William P. Mr. EVP, Chief Financial Officer | Option exercise · Non-qualified Stock Option (Right to Buy) | −11,435 | 0 | ||
| 2021-08-06 | Pomeroy Claire Director | Grant or award | +3,077 | 7,016 | ||
| 2021-08-06 | KROLL MARK W Director | Grant or award | +3,077 | 21,517 |
Page 16 of 17 · 335 trades